These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 10460902)
1. Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy. Ogawa O; Iinuma M; Sato K; Sasaki R; Shimoda N; Satoh S; Kato T Urol Res; 1999 Aug; 27(4):291-6. PubMed ID: 10460902 [TBL] [Abstract][Full Text] [Related]
2. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy. Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986 [TBL] [Abstract][Full Text] [Related]
3. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system. Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386 [TBL] [Abstract][Full Text] [Related]
4. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy. Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912 [TBL] [Abstract][Full Text] [Related]
5. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells. Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802 [TBL] [Abstract][Full Text] [Related]
6. The limited significance of a longer duration of neoadjuvant hormonal therapy prior to radical prostatectomy for high-risk prostate cancer in Japanese men. Miyake H; Sakai I; Inoue TA; Hara I; Fujisawa M Urol Int; 2006; 77(2):122-6. PubMed ID: 16888415 [TBL] [Abstract][Full Text] [Related]
7. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy. Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128 [TBL] [Abstract][Full Text] [Related]
8. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer. Fair WR; Betancourt JE Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380 [TBL] [Abstract][Full Text] [Related]
9. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction. Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of the impact of 3- versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy. Pu XY; Wang XH; Wu YL; Wang HP J Cancer Res Clin Oncol; 2007 Aug; 133(8):555-62. PubMed ID: 17457611 [TBL] [Abstract][Full Text] [Related]
12. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy. Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565 [TBL] [Abstract][Full Text] [Related]
13. Quantification of PSA mRNA levels in peripheral blood of patients with localized prostate adenocarcinoma before, during, and after radical prostatectomy by quantitative real-time PCR (qRT-PCR). Kalfazade N; Kuskucu AM; Karadag S; Sahin S; Aras B; Midilli K; Yilmaz G; Tasci AI Int Urol Nephrol; 2009; 41(2):273-9. PubMed ID: 18584300 [TBL] [Abstract][Full Text] [Related]
14. Induction androgen deprivation plus prostatectomy for stage T3 disease: failure to achieve prostate-specific antigen-based freedom from disease status in a phase II trial. Gomella LG; Liberman SN; Mulholland SG; Petersen RO; Hyslop T; Corn BW Urology; 1996 Jun; 47(6):870-7. PubMed ID: 8677579 [TBL] [Abstract][Full Text] [Related]
15. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction. Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840 [TBL] [Abstract][Full Text] [Related]
16. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer. Tosco L; Laenen A; Briganti A; Gontero P; Karnes RJ; Albersen M; Bastian PJ; Chlosta P; Claessens F; Chun FK; Everaerts W; Gratzke C; Graefen M; Kneitz B; Marchioro G; Salas RS; Tombal B; Van den Broeck T; Moris L; Battaglia A; van der Poel H; Walz J; Bossi A; De Meerleer G; Haustermans K; Van Poppel H; Spahn M; Joniau S Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):407-412. PubMed ID: 28485390 [TBL] [Abstract][Full Text] [Related]
18. [Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens]. Iinuma M; Sato K; Ogawa O; Sasaki R; Kato T Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):548-56. PubMed ID: 10386054 [TBL] [Abstract][Full Text] [Related]
19. Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy. Yates DR; Rouprêt M; Drouin SJ; Comperat E; Ricci S; Lacave R; Sèbe P; Cancel-Tassin G; Bitker MO; Cussenot O Prostate; 2012 Sep; 72(12):1382-8. PubMed ID: 22228175 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy. Naiki T; Kawai N; Okamura T; Nagata D; Kojima Y; Akita H; Yasui T; Tozawa K; Kohri K BMC Urol; 2012 Dec; 12():36. PubMed ID: 23249358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]